Analysts Set Teleflex Incorporated (NYSE:TFX) PT at $139.00

Shares of Teleflex Incorporated (NYSE:TFX) have earned an average rating of “Hold” from the twelve ratings firms that are covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating on the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $139.00.

TFX has been the topic of a number of research reports. Truist Financial raised their price objective on Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a report on Thursday, December 18th. Royal Bank Of Canada restated a “sector perform” rating and issued a $135.00 price objective on shares of Teleflex in a report on Wednesday, December 17th. Wells Fargo & Company reduced their target price on shares of Teleflex from $139.00 to $116.00 and set an “equal weight” rating on the stock in a report on Thursday, January 29th. Wall Street Zen cut Teleflex from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th.

Teleflex Stock Down 0.3%

TFX stock opened at $111.83 on Monday. Teleflex has a 1-year low of $100.18 and a 1-year high of $178.79. The stock has a market cap of $4.94 billion, a price-to-earnings ratio of -15.21, a price-to-earnings-growth ratio of 1.46 and a beta of 0.92. The company has a current ratio of 2.57, a quick ratio of 1.53 and a debt-to-equity ratio of 0.67. The company’s 50 day moving average is $111.44 and its 200 day moving average is $118.67.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Empowered Funds LLC raised its holdings in Teleflex by 15.8% during the 1st quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock valued at $233,000 after buying an additional 230 shares during the last quarter. Jane Street Group LLC raised its stake in shares of Teleflex by 42.6% during the first quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock valued at $877,000 after acquiring an additional 1,895 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of Teleflex during the second quarter worth about $426,000. AlphaQuest LLC grew its stake in shares of Teleflex by 451.2% in the second quarter. AlphaQuest LLC now owns 9,585 shares of the medical technology company’s stock worth $1,134,000 after purchasing an additional 7,846 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd increased its holdings in Teleflex by 16.2% during the 2nd quarter. Y Intercept Hong Kong Ltd now owns 50,541 shares of the medical technology company’s stock valued at $5,982,000 after purchasing an additional 7,038 shares during the period. Institutional investors own 95.62% of the company’s stock.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.